Nucleix's Series A Round

Nucleix raised a round of funding on June 16, 2014. Investors include OrbiMed Advisors.

Nucleix develops, manufactures and markets non-invasive molecular cancer diagnostic tests. The company's sensitive and specific tests are based on identification of subtle changes in methylation patte…

Articles about Nucleix's Series A Round: